NCT05765812 2026-02-27A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaDebiopharm International SAPhase 1/2 Recruiting116 enrolled
NCT03452774 2025-10-28SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryMassive Bio, Inc.Recruiting50,000 enrolled
NCT04971733 2025-06-10A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's DiseaseEisai Inc.Phase 1/2 Completed8 enrolled 21 charts
NCT02590263 2020-09-03Study Evaluating ABT-414 in Japanese Subjects With Malignant GliomaAbbViePhase 1/2 Completed53 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled